Treatment of Haemophilus influenzae Pneumonia

Initial Treatment Selection

The American Academy of Pediatrics and the Infectious Diseases Society of America recommend using amoxicillin-clavulanate or a third-generation cephalosporin for empiric therapy in patients with H. influenzae pneumonia, as 18-42% of H. influenzae isolates produce β-lactamase and are resistant to plain ampicillin or amoxicillin 1, 2
For non-severe pneumonia, the preferred oral regimen is amoxicillin-clavulanate, with a dosage of 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses for children, and standard adult dosing for adults, if β-lactamase producing strains are suspected 1, 2
For patients who are allergic to penicillin, doxycycline or a respiratory fluoroquinolone, such as levofloxacin or moxifloxacin, can be used as an alternative 3, 2

The Infectious Diseases Society of America recommends using ceftriaxone or cefotaxime as the preferred IV regimen for severe H. influenzae pneumonia, with a dosage of 50-100 mg/kg/day every 12-24 hours for children and 1-2g once to twice daily for adults 1
For severe pneumonia, parenteral therapy is mandatory, and the use of fluoroquinolone alternatives, such as IV levofloxacin or IV ciprofloxacin, can be considered 1

The British Thoracic Society recommends a treatment duration of 7 days for non-severe pneumonia and 10-14 days for severe pneumonia, particularly if complications are present 4

The single most important factor determining antibiotic choice is whether the H. influenzae strain produces β-lactamase, and if β-lactamase positive or unknown, β-lactamase-stable agents, such as amoxicillin-clavulanate, cephalosporins, or fluoroquinolones, must be used 1, 2

The Infectious Diseases Society of America advises against using plain ampicillin or amoxicillin empirically without culture confirmation of β-lactamase-negative status, as treatment failure rates are unacceptably high in areas with β-lactamase-producing strains 2
The British Thoracic Society recommends administering parenteral antibiotics within 4 hours of admission for severe cases and ensuring prompt, high blood and lung concentrations 5, 4